In order to minimise adverse affects of NSAIDs, by November 2019, 80%of high risk patients, in a Greenock GP practice, prescribed a long term NSAID, will have had a documented clinical safety review as per NICE and GGC guidelines.

By the end of November 2019, 95% of patients in the practice treated with bisphosphonate therapy for osteoporosis will have a medication review date recorded.

To reduce the number of patients aged over 65 prescribed an ACE Inhibitor/ARB, NSAID and Diuretic by 80% by the end of March 2020 in line with The National Therapeutic Indicators document 2018 2019 produced by the Scottish Government.

The Practice will reduce gabapentinoid prescribing to the weighted Tayside DDD norm (10%) by June 2020 and review all those co prescribed methadone.

To ask every identified frail elderly Polypharmacy patient, who undergoes a pharmacist lead medication review, the Level 1 Falls Intervention questions (with their permission) at least once a year by the end of 2020.

To ensure 90% of patients who are >65 year old and prescribed NSAID medications have PPI cover by Jan 2020.

To offer 100% of women currently administered Depo Provera the option to switch to Sayana Press by May 2020 to improve patient autonomy in line with FSRH guidance.

By April 2020 95% of patients within our GP practice requesting medication to delay periods for social reasons will have VTE risk considered by documenting weight, blood pressure and smoking status before a prescription for either norethisterone...

The aim of the project is for the primary care pharmacy team to complete medicines reconciliation consistently and within the recommended timeframes on at least 95% of patient immediate discharge letters by February 2020.